The Aker BioMarine Group managed a turnaround in the fourth quarter of 2011, recording an operating profit NOK 7 million, compared to an operating loss of NOK 13 million in the corresponding quarter of 2010.
The Oslo-listed company, a manufacturer of omega-3 products, also posted operating revenues of NOK 101 million in the fourth quarter of 2011, up from NOK 87 million from 2010, attributing the increase to higher sales of its Superba™ Krill.
In fact, sale of Superba™ Krill reached a record high of 70 metric tons in the fourth quarter of 2011, and strong demand has carried over into 2012. During the three-month period, five additional customers launched their own krill products based on Superba™ Krill.
Also in the fourth quarter, the company completed the purchase of its second krill-harvesting vessel, Antarctic Sea, which is expected to take to the water in late March.
Looking ahead, Aker BioMarine said it remains “optimistic.”
“Key factors for driving further growth are securing the approvals necessary to gain entry into new markets, development of additional krill products and applications, and continued focus on quality, supply reliability and sustainability,” said the company.
